Form D · Other Health Care

Vavotar Life Sciences LLC

Aspen, CO · CIK 0001661957

Offering snapshot reported Jan 18, 2019 · SEC filing

Reported sold
$10M
Offering amount: $10M
Investors reported
31
Form D · investor count
Minimum accepted
$6.25K
Reported outside-investor minimum
First sale
Nov 5, 2018
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 18, 2019Initial$10,000,000No comparison31SEC filing
Sep 23, 2016Initial$80,833,200No comparison1SEC filing
Sep 22, 2016Initial$21,000,000No comparison3SEC filing
Sep 21, 2016Initial$40,605,000No comparison1SEC filing
May 16, 2016Initial$3,515,000No comparison11SEC filing
Jan 5, 2016Initial$675No comparison8SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$156K (estimated)
Finders' fees
$0
Form D file number
021-330875

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Finsoft Consultants, Inc.None
Virginia DadeyNone
Ashley JohnsonNone

Source: Form D, filed Jan 18, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Martin A. Bell Executive
Jesse W. Crowne Executive
Andrew Danielsen Director
Charles Farrahar Executive
Steve Gorlin Director, Executive
James A. Rogers Director
Patrick Soon Shiong Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
600 E. Hopkins Avenue, #302
Aspen, CO, 81611